Stemline Therapeutics Inc. (STML) Drops 9.73% on January 11

Equities Staff |

Stemline Therapeutics Inc. (STML) was one of the Russell 2000's biggest losers for Monday January 11 as the stock slid 9.73% to $5.19, a loss of $-0.5596 per share. Starting at an opening price of $5.76 a share, the stock traded between $5.14 and $6.26 over the course of the trading day. Volume was 215,655 shares over 1,088 trades, against an average daily volume of 101,916 shares and a total float of 18 million.

The losses send Stemline Therapeutics Inc. down to a market cap of $93.42 million. In the last year, Stemline Therapeutics Inc. has traded between $17.40 and $5.68, and its 50-day SMA is currently $7.51 and 200-day SMA is $10.78.

Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.

Stemline Therapeutics Inc. is based out of New York, NY and has some 27 employees. Its CEO is Ivan Bergstein.

For a complete fundamental analysis analysis of Stemline Therapeutics Inc., check out’s Stock Valuation Analysis report for STML. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Nano One Materials Corp.

Nano One Materials Corp is a technology company. The Company manufactures storage materials for lithium ion batteries.

Private Markets


Airbnb is a community marketplace for people to list, discover, and book unique accommodations around the world — online or from a mobile phone. Whether an apartment for a night,…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…